Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma

NCT00460109

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 165 locations

View Trial Details

Completed

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

NCT00993694

Conditions: Amyloidosis, Anemia, Anemia, Aplastic, +101 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)

NCT01120834

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

NCT00594815

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

NCT00005988

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +47 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Minnesota Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

NCT00490009

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

NCT00079105

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany

Wansbeck General Hospital Ashington, England, United Kingdom

Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Royal United Hospital Bath, England, United Kingdom

View all 54 locations

View Trial Details

Completed

Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

NCT00897923

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +50 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab

NCT00238238

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States

View all 79 locations

View Trial Details

Completed

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

NCT00880581

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions